| Literature DB >> 36012920 |
Begoña Espejo1, Marta Martín-Carbonell2, Kelly Carolina Romero-Acosta3, Martha Fernández-Daza2, Yadid Paternina3.
Abstract
BACKGROUND: Having a valid tool to assess attitudes toward vaccination and identify the concerns that drive vaccine refusal can facilitate population studies and help guide public health interventions. The objective of this study has been to adapt the Vaccination Attitudes Examination (VAX) scale in Colombian university students and to study its psychometric properties in a non-probabilistic sample of 1074 Colombian university students.Entities:
Keywords: COVID-19; concurrent validity; confirmatory factor analysis; measurement invariance; psychometric properties; structural equation modeling; vaccine hesitancy; vaccine refusal
Year: 2022 PMID: 36012920 PMCID: PMC9409776 DOI: 10.3390/jcm11164682
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Frequencies and percentages of sociodemographic variables (N = 1197).
| n | % | ||
|---|---|---|---|
| Gender | Male | 388 | 32.4 |
| Female | 791 | 66.8 | |
| Non-binary | 3 | 0.3 | |
| Prefer not to answer | 7 | 0.6 | |
| Student condition | Full-time student | 707 | 59.1 |
| Work and study | 490 | 40.9 | |
| Socioeconomic level | High | 9 | 0.8 |
| Medium-high | 93 | 7.8 | |
| Medium | 435 | 36.3 | |
| Medium-low | 412 | 34.4 | |
| Low | 248 | 20.7 | |
| Provincial department where the studies were carried out | Amazonas | 1 | 0.1 |
| Antioquia | 80 | 6.7 | |
| Arauca | 2 | 0.2 | |
| Atlántico | 61 | 5.1 | |
| Bolívar | 14 | 1.2 | |
| Boyacá | 3 | 0.3 | |
| Casanare | 1 | 0.1 | |
| Cauca | 12 | 1.0 | |
| César | 22 | 1.8 | |
| Córdoba | 34 | 2.8 | |
| Guainía | 1 | 0.1 | |
| La Guajira | 13 | 1.1 | |
| Magdalena | 572 | 47.8 | |
| Meta | 4 | 0.3 | |
| Norte de Santander | 18 | 1.5 | |
| Santander | 16 | 1.3 | |
| Sucre | 338 | 28.2 | |
| Tolima | 1 | 0.1 | |
| Valle del Cauca | 4 | 0.3 | |
| Degree being studied | Psychology | 339 | 28.3 |
| Social work | 82 | 6.9 | |
| Architecture | 149 | 12.4 | |
| Medicine | 22 | 1.8 | |
| Law | 79 | 6.6 | |
| Nursing | 52 | 4.3 | |
| Engineering | 88 | 7.4 | |
| Veterinary | 2 | 0.2 | |
| Other | 384 | 32.1 | |
| How the participants were conducting their studies | Online | 624 | 52.1 |
| Face-to-face | 219 | 18.3 | |
| Combined (online/face-to-face) | 354 | 29.6 | |
| Participants infected with coronavirus | Yes | 353 | 29.5 |
| No | 555 | 46.4 | |
| Not sure | 246 | 20.6 | |
| Missing values | 43 | 3.6 | |
| Participants vaccinated against the coronavirus | Yes | 874 | 73.0 |
| No | 323 | 27.0 |
Figure 1Standardized coefficients for the four-factor model of the Vaccination Attitudes Examination scale. Note: F1 = trust of vaccine benefit; F2 = worries over unforeseen future effects; F3 = concerns about commercial profiteering; and F4 = preference for natural immunity. * p < 0.001.
Descriptive statistics and corrected item-total polyserial correlations for the items of the Vaccination Attitudes Examination Scale.
| Mean | Standard Deviation | Skewness | Kurtosis | Corrected Item-Total Polyserial Correlations | SE for the Corrected Item-Total Polyserial Correlations | |
|---|---|---|---|---|---|---|
| Item 1 | 3.57 | 1.01 | −0.59 | 0.14 | 0.779 | 0.006 |
| Item 2 | 3.65 | 0.99 | −0.67 | 0.26 | 0.763 | 0.007 |
| Item 3 | 3.54 | 0.95 | −0.46 | 0.11 | 0.829 | 0.005 |
| Item 4 | 3.71 | 0.85 | −0.71 | 0.83 | 0.441 | 0.018 |
| Item 5 | 3.16 | 0.83 | −0.11 | 0.40 | 0.515 | 0.016 |
| Item 6 | 3.43 | 1.02 | −0.42 | −0.26 | 0.569 | 0.014 |
| Item 7 | 3.21 | 0.95 | −0.12 | −0.08 | 0.656 | 0.011 |
| Item 8 | 3.02 | 0.99 | 0.01 | −0.18 | 0.725 | 0.008 |
| Item 9 | 2.69 | 0.95 | 0.20 | 0.13 | 0.642 | 0.011 |
| Item 10 | 2.91 | 0.91 | 0.04 | 0.23 | 0.593 | 0.012 |
| Item 11 | 2.73 | 0.96 | 0.10 | −0.11 | 0.706 | 0.009 |
| Item 12 | 2.75 | 0.95 | 0.05 | −0.07 | 0.668 | 0.009 |
Note: SE = standard error.
Measurement invariance by gender models and goodness-of-fit indices. Reference group: Men.
| χ2 | df | Δχ2 | Δdf | CFI | RMSEA | SRMR | ΔCFI | ΔRMSEA | ΔSRMR | |
|---|---|---|---|---|---|---|---|---|---|---|
| Men | 168.71 * | 48 | 0.909 | 0.081 | 0.070 | |||||
| Women | 154.26 * | 48 | 0.954 | 0.053 | 0.048 | |||||
| Configural | 322.98 * | 96 | - | - | 0.937 | 0.063 | 0.056 | - | - | - |
| Metric | 332.91 * | 104 | 10.6 | 8 | 0.936 | 0.061 | 0.060 | −0.001 | −0.002 | 0.004 |
| Scalar | 356.93 * | 112 | 20.0 | 8 | 0.932 | 0.061 | 0.062 | −0.004 | 0.000 | 0.002 |
Note: Δχ2 = chi-square change; Δdf = degrees of freedom change; CFI = comparative fit index; RMSEA = root mean square error of approximation; SRMR = standardized root mean square residual; ΔCFI = CFI change; ΔRMSEA = RMSEA change; and ΔSRMR = SRMR change. * p < 0.001
Figure 2Standardized coefficients for validity model of the Vaccination Attitudes Examination Scale. Reference group for Vaccine: Yes. Note: F1 = trust of vaccine benefit; F2 = worries over unforeseen future effects; F3 = concerns about commercial profiteering; and F4 = preference for natural immunity. * p < 0.001.
Descriptive statistics and percentiles of the subscales of the Vaccination Attitudes Examination Scale.
| F1 | F2 | F3 | F4 | ||
|---|---|---|---|---|---|
| N | Valid | 1197 | 1197 | 1196 | 1197 |
| Missing | 0 | 0 | 1 | 0 | |
| Mean | 10.70 | 10.76 | 10.30 | 8.91 | |
| Median | 11 | 11 | 10 | 9 | |
| Mode | 12 | 12 | 9 | 9 | |
| Standard deviation | 2.70 | 2.64 | 2.10 | 2.44 | |
| Variance | 7.00 | 6.99 | 4.41 | 5.97 | |
| Minimum | 3 | 3 | 3 | 3 | |
| Maximum | 15 | 15 | 15 | 15 | |
| Percentiles | 5 | 6 | 7 | 5 | 4 |
| 10 | 7 | 8 | 6 | 6 | |
| 15 | 9 | 8 | 6 | 6 | |
| 20 | 9 | 9 | 7 | 6 | |
| 25 | 9 | 9 | 7 | 7 | |
| 30 | 9 | 9 | 8 | 7 | |
| 35 | 10 | 10 | 8 | 8 | |
| 40 | 10 | 10 | 9 | 8 | |
| 45 | 11 | 10 | 9 | 9 | |
| 50 | 11 | 10 | 9 | 9 | |
| 55 | 12 | 11 | 9 | 9 | |
| 60 | 12 | 11 | 9 | 9 | |
| 65 | 12 | 11 | 10 | 9 | |
| 70 | 12 | 11 | 10 | 9 | |
| 75 | 12 | 12 | 10 | 9 | |
| 80 | 12 | 12 | 11 | 10 | |
| 85 | 13 | 12 | 11 | 10 | |
| 90 | 15 | 13 | 12 | 11 | |
| 95 | 15 | 14 | 13 | 12 | |
Note: F1 = trust of vaccine benefit; F2 = worries over unforeseen future effects; F3 = concerns about commercial profiteering; and F4 = preference for natural immunity.